HPC
RVMD icon

HM Payson & Co’s Revolution Medicines RVMD Stock Holding History

HM Payson & Co’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.36K Buy
+50
New +$7.3K ﹤0.01% 930

Other funds holding RVMD

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
SCA
Sandy Cove Advisors Hingham, Massachusetts $400M AUM 27.68% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

HM Payson & Co's RVMD Position: Q2 2026 in Review

HM Payson & Co opened a new position in Revolution Medicines (RVMD) in Q2 2026: 50 shares worth $9.36K. The stake represents ﹤0.01% of the portfolio and ranks #930 among its holdings.

82 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • HM Payson & Co held 50 shares of Revolution Medicines worth $9.36K as of Q2 2026.
  • Revolution Medicines was a new HM Payson & Co position in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #930 holding.
  • 82 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.